UNSPSC 51282201: Cefotetan

This classification denotes a cephalosporin antibiotic with the molecular formula C17H17N7O8S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48SPP0PA9Q, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha))- but generally known as cefotetan, which bears US NIH Compound Identifier 50614.

UNSPSC 51282201 Cefotetan is a Commodity code identifying a specific third-generation cephalosporin antibiotic, yet the recent state and local procurement activity tagged under this code does not reflect cefotetan purchases. Instead, the posted opportunities show state and local health authorities procuring unrelated pharmaceutical products and medical supplies — doxycycline hyclate and ciprofloxacin tablets through a piggyback pharmaceutical warehouse contract, and naloxone with drug deactivation systems through a county health initiative. The mismatch suggests either misclassification in the source data or that state and local procurement offices are applying this code to broader pharmaceutical acquisition activity rather than to cefotetan specifically. State issuing bodies and county health departments are the primary buyers under the code's recent activity, reflecting procurement for public health and emergency preparedness programs.

The most recent visible opportunities span Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets, with a total contract value of $2,999,999.11 over three years including renewals; this was a completed award, not an open solicitation. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. Neither opportunity involves cefotetan procurement, making this code a poor fit for firms pursuing antibiotic-supply contracts with state and local governments.